March 25, 2025 - 19:12

Washington – The Senate has confirmed Michael Kratsios to lead the Office of Science and Technology Policy. Kratsios previously served under the Trump administration as the Chief Technology Officer of the United States, where he played a pivotal role in shaping the country’s technology policy.
His confirmation comes at a crucial time as the nation faces numerous challenges in the fields of science and technology, including cybersecurity threats, climate change, and the ongoing impact of the COVID-19 pandemic. Kratsios is expected to bring his extensive experience in technology and innovation to the forefront of national policy discussions.
The Office of Science and Technology Policy is responsible for advising the President on matters related to science and technology, and Kratsios' leadership is anticipated to influence key initiatives in areas such as artificial intelligence, biotechnology, and space exploration. His appointment signals a commitment to harnessing technology for the benefit of the American public and ensuring that the U.S. remains at the forefront of global scientific advancements.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...